New to corneal collagen crosslinking? This Q&A guide from Wills Eye Hospital will help prepare you to manage keratoconus patients in the new era. This guide to crosslinking for ophthalmologists may be of interest to you too.
Happy and healthy New Year from the Keratoconus Australia team. We wish you a safe holiday season and all the best with managing your keratoconus in the coming year. We will be back soon to assist you in every way possible You can assist our work by donating to the Association straight from your beach
The head of the Australian Crosslinking Registry, Professor Stephanie Watson, presented the latest results from the registry on crosslinking at meetings in Melbourne and Sydney. The full video of her presentation can be viewed here Her slideshow presentation (pdf format) can be downloaded below Professor Watson Nov 2017 talk
Keratoconus Australia Inc held its Annual General Meeting on Tuesday, November 28, 2017 at 6 pm at Suite 1302, Level 13, 9 Yarra St, South Yarra VIC 3141. Agenda – Adoption of minutes of the AGM 2016 – Committee report on the Association’s activities in 2016-17 – Financial accounts for the year ending June 30
Optometry Australia News Collagen corneal cross-linking appears to stabilise keratoconus in patients who undergo the procedure, according to early results of a world-first keratoconus registry based in Australia. Ophthalmologist Professor Stephanie Watson has completed initial analysis of data from 1,062 keratoconic patients in Australia and New Zealand including adults, teenagers and children who had
Professor Stephanie Watson gave an outstanding talk at Keratoconus Australia’s meeting in Melbourne, outlining the latest results on cross linking from the Australian KC registry. There are some surprising data emerging from the new registry regarding how CXL works at different ages. She spoke again at the SSI-KA Keraclub seminar in Sydney on November 2.
CORNEAL CROSSLINKING AND WHY THE NEW AUSTRALIAN CROSSLINKING REGISTRY IS IMPORTANT TO YOU Speaker Professor Stephanie Watson. Save Sight Institute and head of the Australian Crosslinking Registry project Dates Melbourne Tuesday, 24 October, 2017 at 6:45 – 8:30 pm Amies Theatre The Australian College of Optometry Cnr of
Welcome to the September 2017 KA iNews. Topics this month include New Website and Logo Launch Crosslinking and contact lenses events in Melbourne and Sydney A call for volunteers for a UNSW study of differences in corneal thickness of keratoconus and non-patients. NEW WEBSITE and LOGO LAUNCH We are delighted to announce the
Thursday, 2 November 2017 from 6:00 pm to 8:30 pm (AEDT) Sydney Eye Hospital, Claffy Lecture Theatre 8 Macquarie Street Sydney, NSW 2000 Australia Your opportunity to learn more about keratoconus and its management, to ask questions and to hear from others about their experiences living with keratoconus. Clinical Professor Stephanie Watson, a corneal specialist
FDA-approved corneal collagen cross-linking is barely a year old (in the United States). The Avedro KXL UV system, along with Photrexa and Photrexa Viscous, is approved for patients aged 14 and up with progressive keratoconus or post-surgical ectasia. After years of commercial use abroad, this long-awaited therapeutic option has the potential to halt vision loss